科倫藥業(002422.SZ):肝素鈉封管注射液獲藥品註冊批件
格隆匯11月11日丨科倫藥業(002422.SZ)公佈,公司子公司湖南科倫製藥有限公司於近日獲得國家藥品監督管理局核准簽發的化學藥品“肝素鈉封管注射液”的《藥品註冊批件》。
藥品名稱:肝素鈉封管注射液;劑型:注射劑;規格:5ml:500單位;申請事項:國產藥品註冊註冊分類:原化學藥品第6類申報階段:生產;受理號:CYHS1302137;藥品批准文號:國藥準字H20193311;審評結論:根據《中華人民共和國藥品管理法》及有關規定,經審查,本品符合藥品註冊的有關要求,批准註冊,發給藥品批准文號。
肝素鈉封管注射液用於維持靜脈內注射裝置(如留置針、導管)的管腔暢通,可於靜脈內放置注射裝置後、每次用藥後以及每次採血後使用本品。
靜脈留置針因適用於任何部位的穿刺,減輕患者痛苦、提高護理工作效率等優點,臨牀廣泛應用於患者的連續性或長期靜脈輸液治療。中心靜脈置管主要用於急危重症和內瘻成熟前的血液透析,已成為建立血液淨化血管通路的常用方式。為減少管腔內閉塞和導管相關血流感染風險,每次輸液完成或血液透析完成後,均需使用封管液封閉血管通路裝置。
肝素能抑制凝血因子Xa以及其他蛋白酶,抑制血栓形成,具有降低堵管率、延長留管時間的優點。《美國輸液治療標準(2016版)》推薦生理鹽水和低濃度肝素用於留置針封管,且低濃度肝素能減少經外周靜脈置入的中心靜脈導管反應延遲、阿替普酶的使用等,具有重要臨牀意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.